Phibro Animal Health | PAHC - Des Atouts





Des Atouts Changement Date
Align Technology USD 6.31B 80.48M 2026-03
ANI Pharmaceuticals USD 1.42B 18.41M 2026-03
Aurora Cannabis CAD 601.09M 174.2M 2026-03
Bristol-Myers Squibb USD 86.48B 3.56B 2026-03
Canopy Growth CAD 1.12B 12.54M 2026-03
Corcept Therapeutics USD 814.88M 21.77M 2026-03
Eli Lilly USD 116.58B 4.1B 2026-03
Henry Schein USD 11.3B 89M 2026-03
Idexx Laboratories USD 3.39B 34.74M 2026-03
Knight Therapeutics CAD 1.05B 2.28M 2025-12
Merck USD 128.68B 8.18B 2026-03
Nektar Therapeutics USD 280.41M 20.94M 2025-12
Pacira USD 1.21B 56.38M 2026-03
Phibro Animal Health USD 1.45B 39.56M 2026-03
Prestige Brands USD 3.49B 430K 2026-03
Supernus Pharmaceuticals USD 1.5B 48.08M 2026-03
Zoetis USD 15.15B 313M 2026-03